Market Overview

Biolase, Inc. (NASDAQ: BIOL)

1.02 -0.05 (-4.67%)

Analyst Ratings

DateResearch FirmActionCurrentPT
6/19/19BenchmarkInitiates Coverage OnSpeculative Buy2.0
4/25/17Singular ResearchInitiates Coverage OnBuy2.5
5/13/14WallachbethDowngradesHold2.5
9/12/13Sidoti & Co.UpgradesBuy
7/03/13Ascendiant CapitalMaintainsBuy5.5

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter